AI Shows Promise in Detecting Advanced Breast Cancer but Can Miss Some Cases
A study reveals that AI-powered mammography effectively detects many invasive breast cancers but still misses about 14%, highlighting the need for continued radiologist oversight in breast cancer screening.
Recent research conducted by a team at Korea University College of Medicine has highlighted both the strengths and limitations of artificial intelligence (AI) in mammography screening for breast cancer. The study, involving an analysis of 1,097 breast cancer cases diagnosed between 2014 and 2020, found that while AI technology is effective in identifying many invasive breast cancers, it still misses approximately 14% of cases, which could significantly impact patient outcomes if undetected.
The research utilized a Korean AI tool called Lunit Insight MMG to assess the accuracy of AI-assisted mammography. The findings revealed that AI missed 17.2% of luminal-type cancers, 14.5% of triple-negative cancers, and 9% of HER2-positive cancers. Notably, missed invasive cancers tended to occur in younger women, with tumors that were 2 cm or smaller, and exhibited features such as low histologic grade, fewer lymph node metastases, low Ki-67 expression, and locations outside the glandular areas. Many of these undetected tumors were classified as BI-RADS category 4 and were associated with dense breast tissue, microcalcifications, and structural distortions, which can complicate detection.
Despite these challenges, a significant portion of these cancers (61.7%) were deemed detectable by radiologists, emphasizing that AI should serve as an assistive tool rather than a standalone diagnostic method. Professor Sungeun Song emphasized that continuous oversight and collaboration between AI and radiologists are essential for optimizing breast cancer detection. Understanding which invasive cancers are more likely to be missed by AI can help refine these technologies and improve their clinical application.
The study’s publication in the journal Radiology underscores the importance of ongoing evaluation of AI tools in medical diagnostics. While AI shows promising results, this research indicates that it is not infallible and reinforces the need for radiologist expertise to ensure accurate breast cancer detection and timely treatment.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Sudan Battles Its Most Severe Cholera Outbreak in Years with Over 40 Fatalities
Sudan faces its worst cholera outbreak in years, with over 40 fatalities amid ongoing conflict and displacement, highlighting urgent needs for aid and improved sanitation.
Effective Strategies for Supporting Autistic Patients in Healthcare Settings
Learn how healthcare providers can better support autistic patients through tailored accommodations, inclusive communication, and recognizing diverse presentations to improve health outcomes.
Aging Reduces Overactive Immune Genes, Leading to Improvement in Lupus Symptoms in Older Adults
Aging appears to diminish the activity of immune-related genes in lupus patients, potentially leading to symptom improvement in older adults. This discovery opens new possibilities for age-specific treatments and understanding disease progression.
'Fast-Fail' AI Blood Test Offers Rapid Assessment for Pancreatic Cancer Treatment Response
Researchers at Johns Hopkins have developed a rapid AI-powered blood test that detects tumor DNA fragments, enabling quicker assessment of treatment response in pancreatic cancer patients—potentially transforming personalized care.